{
    "pubmed_id": 35129576,
    "study_identifier": "PMID35129576_study-01",
    "study_name": "Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection",
    "publication_title": "Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection",
    "study_objective": "To evaluate the persistence of vaccine-induced maternal anti-S IgG in infant blood and compared persistence of infant anti-S IgG after maternal vaccination vs natural infection.",
    "study_description": "Understanding the persistence of maternal antibody levels in infants is important because COVID-19 infections in this age group account for a disproportionate burden of pediatric SARS-CoV-2\u2013associated morbidity6 and because COVID-19 vaccines are not currently planned for administration to infants younger than 6 months. Study limitations include the small number of infants, the longer mean time to follow-up in the infected group (due to pragmatic constraints related to timing of COVID-19 surges in Boston and the availability of participants for timely follow-up), and the reporting of antibody titers rather than clinical outcomes. Although the antibody titer known to be protective against COVID-19 in infants is unknown, these findings provide further incentive for pregnant individuals to pursue COVID-19 vaccination.",
    "primary_institution_name": "Harvard University",
    "study_personnel": [
        {
            "personnel_id": "PMID35129576_personnel-01",
            "honorific": "",
            "last_name": "Alter",
            "first_name": "Galit",
            "suffixes": "",
            "organization": "Harvard University",
            "orchid_id": "",
            "email": "galter@mgh.harvard.edu",
            "seronet_title_in_study": "SeroNet Investigator",
            "role_in_study": "Co-Principal Investigator",
            "site_name": "Harvard University"
        },
        {
            "personnel_id": "PMID35129576_personnel-02",
            "honorific": "",
            "last_name": "Atyeo",
            "first_name": "Caroline",
            "suffixes": "",
            "organization": "Harvard University",
            "orchid_id": "",
            "email": "catyeo@mgh.harvard.edu",
            "seronet_title_in_study": "SeroNet Investigator",
            "role_in_study": "Investigator",
            "site_name": "Harvard University"
        }
    ],
    "study_file": [
        {
            "study_file_name": "PMID35129576_v1.2.4.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors.",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [],
    "research_focus": "Immune Response",
    "study_type": "Clinical Research",
    "keyword": [
        "Antibodies Viral blood",
        "COVID-19 blood",
        "COVID-19 immunology",
        "COVID-19 Vaccines",
        "Female",
        "Humans",
        "Infant",
        "Pregnancy",
        "Spike Glycoprotein",
        "Coronavirus immunology",
        "Time Factors"
    ],
    "clinical_study_design": "Prospective Cohort",
    "in_silico_model_type": "",
    "protocol": {
        "protocol_id": "PMID35129576_protocol-01",
        "protocol_file_name": "PMID35129576_protocol-01.txt",
        "protocol_name": "PMID35129576_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19"
    ],
    "sars_cov_2_vaccine_type": [
        "Pfizer-BioNTech",
        "Moderna"
    ],
    "clinical_outcome_measure": "Persistence of anti-spike antibodies in infants",
    "enrollment_start_date": "2021-07-21",
    "enrollment_end_date": "2021-10-22",
    "number_of_study_subjects": 89,
    "age_unit": "Years",
    "minimum_age": 31,
    "maximum_age": 37,
    "study_human_cohort": [
        {
            "arm_id": "PMID35129576_human_subject-01",
            "arm_name": "Vaccinated pregnant women",
            "study_population_description": "77 vaccinated pregnant women",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Massachusetts"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Vaccinated"
            ],
            "sars_cov_2_vaccine_type": [
                "Pfizer BioNTech COVID-19 vaccine ; VO:0004987",
                "Moderna COVID-19 vaccine ; VO:0005157"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35129576_human_subject-02",
            "arm_name": "SARS-CoV-2 Infected pregnant women",
            "study_population_description": "12 Infected symptomatic pregnant women",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Massachusetts"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Acute COVID-19 (< 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [
                "Mild I Moderate I Severe"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID35129576_visit-01",
            "visit_name": "Capillary serum samples collected from 49 infants of vaccinated mothers",
            "visit_order_number": 1,
            "visit_min_start_day": 60,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35129576_visit-02",
            "visit_name": "At 6 months, serum samples collected from 28 infants of vaccinated mothers (mean, 170 days after birth)",
            "visit_order_number": 2,
            "visit_min_start_day": 170,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35129576_visit-03",
            "visit_name": "Serum sampleS collected from 12 infants of infected mothers on mean 207 days after birth",
            "visit_order_number": 3,
            "visit_min_start_day": 207,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID35129576_human_subject-01"
            ],
            "associated_first_planned_visit_id": [
                "PPMID35129576_visit-01",
                "PMID35129576_visit-02"
            ],
            "assay_type": "ELISA",
            "experiment_name": "ELISA",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Serum"
            ],
            "biospecimen_collection_point": [
                "Post vaccination"
            ],
            "sars_cov_2_antigen": [
                "Full Length Spike Trimer"
            ],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2"
            ],
            "antibody_isotype": [
                "IgG"
            ],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        },
        {
            "arm_id": [
                "PMID35129576_human_subject-02"
            ],
            "associated_first_planned_visit_id": [
                "PMID35129576_visit-03"
            ],
            "assay_type": "ELISA",
            "experiment_name": "ELISA",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Serum"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [
                "Full Length Spike Trimer"
            ],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2"
            ],
            "antibody_isotype": [
                "IgG"
            ],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        }
    ],
    "geriatric_subjects": "No",
    "pediatric_subjects": "Yes",
    "pregnant_subjects": "Yes",
    "sars_cov_2_antibodies_measured": "Not Specified",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID35129576_inexcl-01",
            "inclusion_criterion": "Geriatric subjects",
            "inclusion_criterion_category": "exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35129576_inexcl-02",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35129576_inexcl-03",
            "inclusion_criterion": "Pregnant subjects",
            "inclusion_criterion_category": "inclusion"
        }
    ]
}
